Bronchial stenosis: An underreported complication of high-dose external beam radiotherapy for lung cancer?

International Journal of Radiation Oncology Biology Physics

Volumn 61, Issue 1, 2005, Pages 64-69

  Miller, Keith L ^a   Shafman, Timothy D ^a   Anscher, Mitchell S ^a   Zhou, Su Min ^a   Clough, Robert W ^a   Garst, Jennifer L ^a   Crawford, Jeffrey ^a   Rosenman, Julian ^b   Socinski, Mark A ^c   Blackstock, William ^d   Sibley, Gregory S ^e   Marks, Lawrence B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e Sibley Hospital   (United States)

Author keywords

Bronchial stenosis; Dose escalation; Lung cancer; Radiotherapy

Indexed keywords

BIOMEDICAL ENGINEERING; COMPUTERIZED TOMOGRAPHY; DISEASE CONTROL; DRUG DOSAGE; RADIOTHERAPY; TUMORS;

BEAM RADIATION THERAPHY; BRONCHIAL STENOSIS; BRONCHOSCOPY; LUNG CANCER;

PATIENT MONITORING;

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BEAM THERAPY; BRONCHUS STENOSIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME;

BRONCHI; CARCINOMA, NON-SMALL-CELL LUNG; CONSTRICTION, PATHOLOGIC; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY DOSAGE;

EID: 19944364831     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.02.066     Document Type: Article

References (26)

1. Jemal A., Taylor M., Samuels A., et al. Cancer Statistics 2003. CA Cancer J Clin. 53:2003;5-26
2. Dillman R.O., Herndon J., Seagren S., et al. Improved survival on stage III non-small cell lung cancer Seven year follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial. J Natl Cancer Inst. 88:1996;1210-1215
3. Sause W., Kolesar P., Taylor S. IV, et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest. 117:2000;358-364
4. Perez C.A., Stanley K., Grundy G., et al. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung Report by the Radiation Therapy Oncology Group. Cancer. 50:1982;1091-1099
5. Speiser B.L., Spratling L. Remote afterloading brachytherapy for the local control of endobronchial carcinoma. Int J Radiat Oncol Biol Phys. 25:1993;579-587
6. Hayman J.A., Martel M.K., Ten Haken R.K., et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy Update of a phase I trial. J Clin Oncol. 19:2001;127-136
7. Saunders M., Dische S., Barrett A., et al. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer Mature data from the randomised multicenter trial. Radiother Oncol. 52:1999;137-148
8. Maguire P.D., Marks L.B., Sibley G.S., et al. 73.6 Gy and beyond Hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer. J Clin Oncol. 19:2001;705-711
9. Cox J.D., Azarnia N., Byhardt R.W., et al. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 to 79.2 Gy Possible survival benefit with >69.6 Gy in favorable patients with Radiation Therapy Oncology Group Stage III non-small-cell lung carcinoma - Report of Radiation Therapy Oncology Group 83-11. J Clin Oncol. 8:1990;1543-1555
10. Rosenman J.G., Halle J.S., Socinski M.A., et al. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer Technical issues and results of a phase I/II trial. Int J Radiat Oncol Biol Phys. 52:2002;348-356
11. Belderbos J.S.A., De Jagier K., Heemsbergen W.D., et al. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Radiother Oncol. 66:2003;119-126
12. Rosenzweig K.E., Mychalczak B., Fuks Z., et al. Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer. Cancer J. 6:2000;82-87
13. Speiser B.L., Spratling L. Radiation bronchitis and stenosis secondary to high dose rate endobronchial irradiation. Int J Radiat Oncol Biol Phys. 25:1993;589-597
14. Hayakawa K., Mitsuhashi N., Saito Y., et al. Short communication Adverse chronic effects of high-dose irradiation on proximal bronchus in patients treated for bronchogenic carcinoma. Br J Radiol. 66:1993;477-479
15. King S.C., Acker J.C., Kussin P.S., et al. High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer Unusual toxicity and promising early results. Int J Radiat Oncol Biol Phys. 36:1996;593-599
16. Socinski M.A., Marks L.B., Garst J., et al. Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy A preliminary report of phase I dose escalation trial from the Carolina Conformal Therapy Consortium. Oncologist. 6:(Suppl. 1):2001;20-24
17. Anscher M.S., Marks L.B., Shafman T.D., et al. Risk of long-term complications after TGF-beta 1-guided very-high-dose thoracic radiotherapy. Int J Radiat Oncol Biol Phys. 56:2003;988-995
18. Trotti A., Byhardt R., Stetz J., et al. Common Toxicity Criteria, version 2.0 An improved reference to grading the acute effects of cancer treatment - Impact on radiotherapy. Int J Radiat Oncol Biol Phys. 47:2000;3-47
19. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481
20. Rostom A.Y., Morgan R.L. Results of treating primary tumours of the trachea by irradiation. Thorax. 33:1978;387-393
21. Dechambre S, Dorzee J, Fastrez, J et al. Bronchial stenosis and sclerosing mediastinitis: An uncommon complication of external thoracic radiotherapy. Eur Respir J 1998;11:1188-1190
22. Miller K.L., Harrell J.H. II. Obstructing endobronchial bands complicating radiation therapy for lung carcinoma. Chest. 101:1992;1714-1715
23. Miller K.L., Zhou S.M., Barrier R.C., et al. Long-term changes in pulmonary function tests after definitive radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 56:2003;611-615
24. Komaki R., Lee J.S., Kaplan B., et al. Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer Preliminary results. Semin Radiat Oncol. 12:(Suppl. 1):2002;46-49
25. Antonadou D., Coliarakis N., Synodinou M., et al. Randomized phase III trial of radiation treatment ± amifostine in patients with advanced-stage lung cancer. Int J Radiat Oncol Biol Phys. 51:2002;915-922
26. Yie E.S., Williams S.T., Malicki D.M., et al. Keratinocyte growth factor ameliorates radiation- and bleomycin-induced lung injury and mortality. Am J Pathol. 149:1996;1963-1970